XML 47 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
 12 Months Ended
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Cash flows from operating activities:      
Net loss $ (12,795) $ (81,764) $ (94,650)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 52,905 48,515 44,671
Reduction in the carrying amount of right-of-use assets 15,358 12,642 10,377
Amortization of deferred contract acquisition costs 71,483 55,384 41,034
Accretion of discount on marketable investments (20,818) (11,351) (90)
Provision for credit losses 1,150 989 1,105
Stock-based compensation 166,315 206,292 172,507
Amortization of discount and issuance costs on convertible senior notes 5,478 3,749 3,743
Gain on early extinguishment of debt (6,615) 0 0
Impairment charge of an equity investment 1,250 0 0
Impairment charge related to closure of operating lease facilities 2,202 0 0
Interest on finance lease obligations 264 150 0
Deferred taxes - excluding tax benefit from acquisition 647 53 3,088
Deferred taxes - tax benefit from acquisition (5,482) 0 0
Change in fair value of contingent consideration 0 0 260
Payment of contingent consideration liability in excess of acquisition-date fair value 0 0 (5,900)
Other (1,051) 657 188
Changes in operating assets and liabilities:      
Accounts receivable (14,645) (9,844) (4,899)
Prepaid expenses and other current assets (12,148) (3,532) 661
Deferred contract acquisition costs (104,957) (91,544) (85,197)
Other assets 3,115 (3,988) (319)
Accounts payable 1,057 2,932 845
Accrued and other current liabilities 2,839 (9,274) (7,878)
Deferred revenue (425) 4,958 13,176
Other long-term liabilities (including non-current portions of operating and finance lease liabilities) (1,959) 3,814 (3,857)
Net cash provided by operating activities 143,168 128,838 88,865
Cash flows from investing activities:      
Purchases of marketable investments (1,289,357) (795,002) (435,768)
Proceeds from sales of marketable investments 122,138 1,211 600
Proceeds from maturities of marketable investments 1,132,332 655,588 524,568
Purchases of property and equipment (42,388) (31,234) (52,272)
Capitalization of internal-use software development costs (22,223) (9,537) (3,899)
Payments of initial direct costs 0 0 (266)
Cash paid for an equity investment in a privately-held company 0 0 (2,000)
Cash paid to acquire Acqueon Inc. (167,151) 0 0
Cash settlement to acquire Aceyus, Inc. 99 (80,588) 0
Net cash (used in) provided by investing activities (266,550) (259,562) 30,963
Cash flows from financing activities:      
Proceeds from issuance of 2029 convertible senior notes 731,055 0 0
Payment of debt issuance costs (2,212) 0 0
Payments for capped call transactions associated with the 2029 convertible senior notes (93,438) 0 0
Repayment of outstanding 2023 convertible senior notes at maturity 0 (169) 0
Proceeds from exercise of common stock options 481 9,127 8,522
Proceeds from sale of common stock under ESPP 14,797 15,927 13,413
Payment of employee taxes related to vested RSUs 0 (3,270) 0
Payment of contingent consideration liability up to acquisition-date fair value 0 0 (18,100)
Payment of holdbacks related to acquisitions 0 (500) 0
Payments of finance leases (4,012) (989) 0
Net cash provided by (used in) financing activities 342,725 94,579 (30,232)
Net increase (decrease) in cash, cash equivalents and restricted cash 219,343 (36,145) 89,596
Cash, cash equivalents and restricted cash:      
Beginning of year 144,842 180,987 91,391
End of year 364,185 144,842 180,987
Supplemental disclosures of cash flow data:      
Cash paid for interest 6,593 3,897 3,744
Cash paid for income taxes 3,751 1,589 1,033
Non-cash investing and financing activities:      
Equipment purchased and unpaid at period-end 11,890 11,243 12,332
Capitalization of leasehold improvement through non-cash lease incentive 37 0 109
Acquisition and related transaction costs accrued at period-end 594 0 0
Stock-based compensation included in capitalized software development costs 8,153 4,085 1,711
Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Consolidated Balance Sheets - Beginning of Period and End of Period:      
Cash and cash equivalents 362,546 143,201 180,520
Restricted cash in other assets 1,639 1,641 467
Total cash, cash equivalents and restricted cash 364,185 144,842 180,987
Convertible Senior Notes, Due 2023      
Cash flows from financing activities:      
Repurchase of a portion of convertible senior notes, net of costs 0 0 (34,067)
Cash received from the settlement at maturity of the outstanding capped calls associated with the 2023 convertible senior notes 0 74,453 0
Convertible Senior Notes, Due 2025      
Cash flows from financing activities:      
Repurchase of a portion of convertible senior notes, net of costs (304,485) 0 0
Cash received from the settlement at maturity of the outstanding capped calls associated with the 2023 convertible senior notes $ 539 $ 0 $ 0